SomnoMed Limited’s shares are listed on the Australian Securities Exchange.

Annual Reports

2015 Annual Report
2014 Annual Report
2013 Annual Report
2012 Annual Report
2011 Annual Report
2010 Annual Report

ASX Announcements – Q2 2016 (October 2015 – December 2015)

SOM Appendix 3B6
SomnoMed acquires Strong Dental, Canada
SOM Appendix 3YLA
SOM Appendix 3YPN
SOM Appendix 3B
SomnoMed exceeds 250,000 patients
SomnoMed  Proxy 2015
Notice of AGM  of SomnoMed 2015
SOM Appendix 3B
GROWTH ACCELERATION IN THE US LEADS TO NEW RECORD QUARTER

ASX Announcements – Q1 2016 (July 2015 – September 2015)

SOM Appendix 4C
SomnoMed Appendix 4G September 2015
New Investor Form 603_090915
SomnoMed Appendix 3B_July 2015
SomnoMed Announcement – Strong Finish to Financial Year – July 2015

ASX Announcements – Q4 2015 (April 2015 – June 2015)

SomnoMed Appendix 4C June 2015 Quarter
DentitracFDA ASX Jun2015
Ceasing to be a Substantial holder_July 2015
SomnoMed Update May 2015
Announcement: SOMNOMED TO ACQUIRE 100% OF SMH BIOMATERIAL AG 
Appendix 3B

ASX Announcements – Q3 2015 (January 2015 – March 2015)

Continuous Growth of SomnoMed in Third Quarter
Appendix 4C Quarterly (Q3)
Ceasing to be a substantial shareholder
Addition of SomnoMed to Australian All Ordinaries Index 
Ceasing to be a substantial shareholder
Appendix 3B New issue announcement
Appendix 4D and Half-Year Financial Review
Investor Presentation: Financial Year 2014-2015 Half Year Review
SomnoMed Achieves Growth Targets
Appendix 3B New Issue Announcement January 2015
Appendix 4C Quarterly

ASX Announcements – Q2 2015 (October 2014 – December 2014)

Form 604 TDM Asset Management December 2014
Appendix 3B New Issue Announcement December 2014
Appendix 3YRS December 2014 – Change of Director’s Interest Notice
Appendix 3YLA – Change of Director’s Interest Notice
Appendix 3YPN – Change of Director’s Interest Notice
Appendix 3YRS – Change of Director’s Interest Notice
Form 604 Belgove December 2014
Appendix 3B New Issue Announcement: application for quotation of additional securities and agreement
Annual Meeting Minutes
SOM Shareholder Change Form Form 604
SomnoMed Exceeds 200,000 Patients
ASX Investor Presentation November 2014
SomnoMed Limited (SOM) Q1 Stock Analysis, Morgans CIMB
SomnoMed Limited (SOM) Q1 Stock Analysis, Wilson HTM
Notice of Annual General Meeting
SomnoMed Limited Proxy Form
Appendix 3B – New issue announcement,application for quotation of additional securities and agreement
New Records in September Confirm Guidance (ASX:SOM)
Appendix 4C – Quarterly report for entities admitted on the basis of commitments 

ASX Announcements – Q1 2015 (July 2014 – September 2014)

US Medicare reimbursement approval granted for SOMNODENT® Herbst Advance 
Appendix 3B New issue announcement
SOM:ASX 2014 SHARE PURCHASE PLAN – CLOSES OVERSUBSCRIBED
SomnoMed (“SOM”-ASX) Preliminary final report – 30 June 2014
SOM – Investor Presentation FY14
Appendix 3YLA – Change of Director’s Interest Notice
Appendix 3Y – Change of Director’s Interest Notice
SOM – Change in Substantial Holding
SomnoMed (“SOM”-ASX) Share Placement Update
SomnoMed SOM 708A Cleansing
SomnoMed Limited Appendix 3B – New Issue Announcement
SomnoMed (SOM) Research
SomnoMed Italy

ASX Announcements – Q4 2014 (April 2014 – June 2014)

Appendix 3B_New Issue Annoucement_June 2014
SomnoMed Appendix 4C_June 2014

SomnoMed Q4 Final
SomnoDent Fusion 510k_June 14

SomnoMed Launches New Products at AADSM
SomnoMed – Spain
SomnoMed Enters the UK
Appendix 3B_New Issue Announcement
Form 604_Notice of Change of interests of substantial holder

ASX Announcements – Q3 2014 (January 2014-March 2014)

Appendix 4C_Quarterly report Notice of ceasing to be a substantial holder
Notice of change of interest of substantial holder SomnoMed Growth_Q3
Notice of ceasing to be a substantial holder
SomnoMed Growth_Q3

ASX Announcements – Q2 2014 (October 2013-December 2013)

Appendix 3B_New Issue Announcement
Appendix 3B_New Issue announcement
Appendix 3Y_Change of Director’s Interest
Appendix 4C_Quarterly Report
Continuing Global Growth for SomnoMed
Exclusive Agreement Signed for Compliance Measurement
SomnoMed Acquired 2nd Largest OA Company in France
SomnoMed General Meeting_Nov12

ASX Announcements – Q1 2014 (July 2013-September 2013)

Appointment of New US Head
Appointment of new VP managed care
Burkhart Partnership Announcement
SomnoMed Continues to break records in 4th quarter
Appendix 3B New Issue Announcement
Appendix 4C Quarterly Report
SomInvestor Presentation Sept 2012 FINAL
Preliminary Final Report

Every State in the United States of America, and most countries throughout the world have their own laws regulating the types of securities and other investment products which maybe offered to their residents, as well as the process for doing so. As a result, investment in some securities is not available to every interested investor. Accordingly, this information is provided for informational purposes only, and does not constitute an offer or solicitation to buy or sell Somnomed Limited shares in any jurisdiction where such would be prohibited.

All investments involve different degrees of risk. In making any investment you should be aware of your risk tolerance level and financial situations at all times. Furthermore, you should seek professional investment advice before making any investment decisions. Somnomed Limited and/or its shareholders, directors, officers and/or employees make no investment recommendations in respect to any investment made in Somnomed Limited.